-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Cartesian Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2024.
- Cartesian Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$10.3M, a 94.2% increase year-over-year.
- Cartesian Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$77.4M, a 64.8% increase year-over-year.
- Cartesian Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$77.4M, a 64.8% increase from 2023.
- Cartesian Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$220M, a 721% decline from 2022.
- Cartesian Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $35.4M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)